Select Page

Dolphin Medical Services (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039

Dolphin Medical Services Limited

Company Logo Price: ₹3.01
52 Week Low: ₹1.72
52 Week High: ₹3.30
Market Capital: 3.95 Crore (Smallcap)
->
Show Table of Contents

To predict the Dolphin Medical Services's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Dolphin Medical Services Share Price Target For 2024

The line chart displays the monthly closing prices of Dolphin Medical Services with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Dolphin Medical Services shares in 2024, see the table below.

Dolphin Medical Services Share Price Target Table For 2024

Level Value Analysis
2024 Target 3 3.2 (+6.31%) Price Action: Jul 2011 High
2024 Target 2 3.14 (+4.3%) Price Action: Dec 2004 Low
2024 Target 1 3.1 (+2.99%) Price Action: Jan 2011 Low
Current Price 3.01 Dolphin Medical Services's share price as of 24 Dec 2024
Stop Loss 1 2.98 (-1%) Price Action: Feb 2024 High
Stop Loss 2 2.95 (-2%) Price Action: 11 Mar 2024 Low
Stop Loss 3 2.9 (-3.66%) Price Action: 09 Dec 2024 Low

Short-Term Technical Outlook

Current Technical Position: Dolphin Medical Services is showing bullish momentum with price above both 25-day and 50-day moving averages.

Key Technical Level: The 25-day moving average at ₹2.92 serves as the nearest technical reference point.

Historical Returns: 3-month: +50.5% | 6-month: +60.11% | 1-year: +53.57%

Dolphin Medical Services Share Price Target For 2025

The line chart displays the monthly closing prices of Dolphin Medical Services with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Dolphin Medical Services shares in 2025, see the table below.

Dolphin Medical Services Share Price Target Table For 2025

Level Value Analysis
2025 Target 3 4.27 (+41.86%) Price Action: Chart
2025 Target 2 4.19 (+39.2%) Price Action: Chart
2025 Target 1 4.15 (+37.86%) Fibonacci Extension Level 64.90%
Current Price 3.01 Dolphin Medical Services's share price as of 24 Dec 2024
Stop Loss 1 2.75 (-8.64%) Price Action: Nov 2024 High
Stop Loss 2 2.72 (-9.64%) Price Action: Jul 2011 Low
Stop Loss 3 2.69 (-10.64%) Price Action: Jun 2011 Low

Long-Term Technical Outlook

52-Week Range Analysis: Dolphin Medical Services is currently trading near its 52-week high of ₹3.3, showing strong yearly momentum.

Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.

Long-Term Performance: 1-year: +53.57% | 3-year: +8.66% | 5-year: +634.15%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Dolphin Medical Services Share Price Target Chart and Table From 2024, 2025, 2026 to 2039

Year Target 1 Target 1 YoY Chg % Target 2
Current Price ₹3.01
2024 ₹2.40 -20.26% ₹2.44
2025 ₹3.16 +31.66% ₹3.21
2026 ₹3.68 +16.45% ₹4.01
2027 ₹4.56 +23.91% ₹4.95
2028 ₹5.72 +25.43% ₹5.81
2029 ₹5.63 -1.57% ₹5.90
2030 ₹6.51 +15.63% ₹6.84
2031 ₹6.89 +5.83% ₹7.78
2032 ₹7.95 +15.38% ₹8.73
2033 ₹9.43 +18.61% ₹9.57
2034 ₹8.86 -6.04% ₹9.67
2035 ₹9.85 +11.17% ₹10.00
2036 ₹10.10 +2.53% ₹10.25
2037 ₹11.35 +12.37% ₹12.50
2038 ₹13.14 +15.77% ₹13.34
2039 ₹12.30 -6.39% ₹13.44

Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.

Dolphin Medical Services Financial Performance

Metric Value Description
Market Capital 3.95 Crore Market valuation of Dolphin Medical Services's shares.
Revenue (TTM) 67.86 Lakh Total revenue generated by Dolphin Medical Services over the past twelve months.
Net Income (TTM) -10.4 Lakh Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin -12.81% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin +83.68% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+0.86% Change in revenue compared to the previous quarter.
Debt-to-Equity
(D/E) Ratio
0.07 Company's total debt divided by total shareholder equity.
Total Debt 80.29 Lakh Sum of Dolphin Medical Services's current & long-term financial obligations.

Is Dolphin Medical Services A Good Buy For Long Term?

Dolphin Medical Services, a small-cap stock with a market capitalization of 3.95 Crore, presents a mixed picture. While its past performance is impressive, showing YTD returns of 33.67% and a remarkable 204.65% return over five years, current financials raise concerns. A net loss of 10.4 Lakh against a revenue of 67.86 Lakh (TTM) and a significant debt of 80.29 Lakh (Q1 2024-25) indicate a precarious financial position. Therefore, despite the strong historical returns, Dolphin Medical Services is currently a not a good buy for long-term investment due to its substantial debt and negative profitability. Further investigation into the reasons for the loss and debt is crucial before considering any investment.

Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.

All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.